Iambic Therapeutics

News

AI in drug discovery & development: News watch, October 2026

Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.

News

Iambic prices its IPO, seeking to raise up to $160m

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

News

Iambic files IPO after signing up AbbVie as new partner

In the space of a day, Iambic has filed an IPO, released the latest version of its AI platform, and signed a multi-year alliance with AbbVie.

News

Takeda signs $1.7bn AI alliance with Iambic

Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.

News

CB Insights digital health investment report

Digital health hit hard by VC slump in 2023, says report

There’s little doubt that financing for digital health companies remains in the doldrums.

AI in drug discovery & development: News watch, October 2026

Iambic prices its IPO, seeking to raise up to $160m

Iambic files IPO after signing up AbbVie as new partner

Takeda signs $1.7bn AI alliance with Iambic

Digital health hit hard by VC slump in 2023, says report

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

Iambic Therapeutics

Editor's Picks